Planning Post Trial Access Early: Choosing the Right Pathway Before Trials Close
- Defining post trial access obligations at the trial design stage rather than at close out
- Choosing between open label extension, post trial access, or early access before Phase III completion
- Aligning PTA planning with budget, supply availability, and country level feasibility upfront
- Preventing long term, unsustainable obligations by understanding and documenting what was committed to authorities